Fetroja is typically administered by a healthcare provider in a hospital or clinical setting. It can be given as an intravenous (IV) infusion or an intramuscular (IM) injection. The route and frequency of administration depend on the severity and type of infection being treated.

• IV administration: Fetroja is often given through an IV drip over a period of 30 minutes to 2 hours, depending on the severity of the infection.
  
  
• IM injection: Fetroja can also be injected directly into a muscle, typically in the upper arm or thigh.
  
  

Before administering Fetroja, the healthcare provider will assess the patient’s overall health and the infection’s severity. If the infection requires prolonged treatment, the doctor may instruct the patient to continue the medication with a follow-up visit.

It’s important to follow the prescribed dosage and schedule exactly as instructed by the healthcare provider. Missing doses or stopping treatment prematurely may result in the infection returning or developing resistance to the antibiotic.

Fetroja (Ceftriaxone) works by inhibiting the synthesis of the bacterial cell wall. Bacteria are surrounded by a protective cell wall, and this structure is crucial for their survival. Fetroja targets the enzymes that are responsible for the production of the cell wall, thereby weakening and eventually destroying it. Without a proper cell wall, the bacteria are unable to maintain their shape and integrity, leading to their death.

Since Fetroja is effective against a broad spectrum of bacteria, it is used to treat a wide variety of infections, including pneumonia, meningitis, urinary tract infections, skin infections, and bloodstream infections (sepsis). The drug works by binding to specific proteins on the bacterial cell membrane, preventing the bacteria from growing and multiplying.

While Fetroja is an effective treatment, it may cause side effects in some people. Most side effects are mild and temporary, but there are also some more serious potential reactions. Common side effects include:

• Gastrointestinal issues: Some patients may experience nausea, vomiting, diarrhea, or abdominal pain.
  
  
• Allergic reactions: Rash, itching, swelling, and hives are possible side effects of Fetroja. More serious allergic reactions, such as difficulty breathing or anaphylaxis, are rare but require immediate medical attention.
  
  
• Changes in liver function: Fetroja may cause liver enzyme levels to rise. It is important to monitor liver function during treatment.
  
  
• Low white blood cell count: In some cases, Fetroja can lower the number of white blood cells, making the body more susceptible to infections.
  
  
• Increased blood clotting time: This could potentially lead to an increased risk of bleeding, particularly if combined with anticoagulant medications.
  
  
• Kidney issues: Although rare, Fetroja can cause kidney problems, including decreased kidney function.
  
  

Less common side effects may include dizziness, headache, or fatigue. Most side effects are mild, and your doctor will monitor you for any complications while you are receiving treatment.

If you experience any of the following serious side effects, you should immediately contact a healthcare professional:

• Difficulty breathing or swelling of the face or throat (indicating an allergic reaction).
  
  
• Severe diarrhea or blood in stools.
  
  
• Signs of kidney problems, such as reduced urine output or swelling in the feet and ankles.
  
  

Fetroja should be used cautiously in certain groups of patients. It is important to follow medical advice and be aware of potential risks:

• Allergies to cephalosporins or penicillins: People with a history of severe allergies to cephalosporin antibiotics or penicillin may be at increased risk for a reaction to Fetroja.
  
  
• Pregnancy and breastfeeding: Fetroja is classified as a pregnancy category B drug, meaning it is considered safe to use during pregnancy but should only be used if clearly needed. It is not known whether Fetroja passes into breast milk, so consult your doctor if you’re breastfeeding.
  
  
• Kidney and liver function: If you have a history of kidney or liver disease, your doctor may need to adjust your dose or monitor your kidney and liver function more closely.
  
  
• Severe diarrhea: Antibiotics like Fetroja can disrupt the balance of bacteria in the digestive system, leading to an overgrowth of harmful bacteria, such as Clostridium difficile. This can result in severe diarrhea, which may be a sign of a life-threatening infection called C. difficile-associated diarrhea (CDAD).
  
  

Inform your doctor about any pre-existing medical conditions or allergies before starting treatment with Fetroja.

Fetroja may interact with several other medications, so it’s important to inform your healthcare provider about any other drugs you are taking. Some potential interactions include:

• Other antibiotics: Using multiple antibiotics at once, especially other cephalosporins or penicillins, can increase the risk of side effects, particularly gastrointestinal issues.
  
  
• Blood thinners: Fetroja may interact with medications like warfarin, which are used to thin the blood. The combination can increase the risk of bleeding.
  
  
• Probenecid: This drug is used to treat gout and can increase the concentration of Fetroja in the bloodstream, leading to potential side effects.
  
  
• Calcium-containing solutions: In newborns and infants, Fetroja should not be mixed with calcium-containing intravenous solutions as it can cause dangerous precipitates (crystals) to form.
  
  

Always inform your doctor about any other medications you’re currently using, including over-the-counter drugs and supplements.

The dosage of Fetroja depends on the type and severity of the infection. For most adults, the recommended dosage is 1-2 grams once daily. For more severe infections, such as sepsis or meningitis, the doctor may increase the dose or provide more frequent treatments.

• Pneumonia: 1-2 grams once daily.
  
  
• Urinary tract infections: 1-2 grams once daily.
  
  
• Bloodstream infections: 2 grams once daily or divided into multiple doses.
  
  

The duration of treatment typically lasts from 4 to 14 days, depending on the infection’s severity and the patient’s response to the drug.

It is important to take Fetroja exactly as prescribed by your doctor. Skipping doses or stopping treatment too early can lead to treatment failure or the development of antibiotic resistance.

Fetroja is a prescription-only medication, and it should only be administered under the guidance of a healthcare provider. It is typically prescribed for more serious or complicated infections, where other antibiotics may not be effective.

Doctors will usually determine whether Fetroja is the appropriate treatment based on the infection type, severity, and bacterial susceptibility. Since Fetroja is often administered in a hospital setting, healthcare professionals will also monitor the patient closely for side effects or complications

• What is Fetroja used for?
  It is an antibiotic used to treat serious infections caused by Gram-negative bacteria, including those resistant to many other antibiotics.
  Specifically, it is indicated for:

  • Complicated urinary tract infections (cUTI), including pyelonephritis

  • Hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP)

• What are the brand names?
  Fetroja® (U.S. and international).

• What is the active ingredient?
  Cefiderocol, a siderophore cephalosporin antibiotic.

• How does Fetroja work?

  • It acts as a “Trojan horse” antibiotic: cefiderocol binds to iron and uses bacterial iron uptake pathways to enter the bacterial cell.

  • Once inside, it inhibits cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to bacterial death.

  • This mechanism allows it to overcome many forms of antibiotic resistance.

• What type of medication is it?
  A siderophore cephalosporin (β-lactam antibiotic) — the first of its kind.

• How is Fetroja administered?

  • By intravenous (IV) infusion only, over 3 hours.

  • Usually given every 8 hours.

  • Administered in hospitals or specialized care settings.

• What are the available strengths?

  • 1 gram (g) vial for IV reconstitution.

• How long is treatment?
  Typically 7–14 days, depending on the infection and clinical response.

• What bacteria does Fetroja target?
  Effective against a broad range of aerobic Gram-negative bacteria, including:

  • Pseudomonas aeruginosa

  • Acinetobacter baumannii

  • Enterobacterales (e.g., E. coli, Klebsiella pneumoniae)

  • Carbapenem-resistant strains (CRE, CRAB, CRPA)

• What are the common side effects?

  • Diarrhea

  • Constipation

  • Nausea or vomiting

  • Rash

  • Headache

  • Infusion site reactions

• Are there serious side effects?
  Rare, but possible:

  • Clostridioides difficile–associated diarrhea (C. diff infection)

  • Hypersensitivity reactions (rash, hives, anaphylaxis)

  • Liver enzyme elevation

  • Increased mortality in critically ill patients with multidrug-resistant infections (boxed warning)

• What is the FDA warning about?
  Fetroja carries a boxed warning due to increased mortality observed in certain clinical trials, especially in patients with severe multidrug-resistant infections.
  The exact cause is unknown, but careful patient selection and monitoring are required.

• Who should not receive Fetroja?

  • Individuals allergic to cefiderocol, cephalosporins, or other β-lactam antibiotics.

  • Patients with a history of severe allergic reactions (anaphylaxis) to penicillin-type drugs.

• Can Fetroja cause diarrhea?
  Yes — diarrhea, including C. difficile infection, may occur even weeks after therapy ends.

• Can Fetroja be used during pregnancy?
  Use only if clearly needed — animal studies show no harm, but there are no adequate human studies.

• Can I use it while breastfeeding?
  It’s unknown whether cefiderocol passes into breast milk — caution is advised.

• Does Fetroja interact with other medications?
  No major interactions are known, but renal function should be monitored when given with other nephrotoxic agents (e.g., aminoglycosides, vancomycin).

• Does Fetroja affect the kidneys?
  Generally safe, but dose adjustments are needed for patients with kidney impairment.

• How is Fetroja eliminated from the body?
  Primarily excreted unchanged in the urine, making it effective for urinary tract infections.

• Can Fetroja be used in children?
  Currently approved for adults only; pediatric studies are ongoing.

• How should Fetroja be stored?

  • Store dry powder vials at 20°C–25°C (68°F–77°F).

  • Reconstituted solution should be used promptly or refrigerated for up to 24 hours.

• Is there a generic version available?
  No — Fetroja (cefiderocol) is currently brand only.

• Where is Fetroja administered?
  Given in hospitals or infusion centers under medical supervision.